ArticleMolecular autism2026
The Signposting Questionnaire for Autism-2 (SQ-A-2): using input from autistic adults to inform questionnaire development.
Article in Molecular autism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBrief questionnaires help clinicians to identify people who may require in-depth assessment for Autism Spectrum Disorder (hereafter autism) and also facilitate research. However, many current questionnaires do not map onto the latest DSM-5 criteria for autism and were developed by researchers and/or clinicians, with limited input from autistic people. The Signposting Questionnaire for Autism (SQ-A) is a caregiver-report questionnaire for measuring autism signs in children, based on DSM-5 criteria. Here, we developed a revised lifespan version, the SQ-A-2, with input on wording from autistic adults. We tested the SQ-A-2 as a self-report measure in autistic and non-autistic adults, and assessed the impact of the adapted wording on both the psychometric properties and the acceptability of the measure.
methodsThe SQ-A, containing highly discriminating DSM-5 items from a valid clinical interview, was revised to form the 18-item SQ-A-2, with self- and informant-report options. Following input from a team of four autistic consultants and six autism professionals, item wording on the SQ-A-2 was adapted, thus forming Original and Adapted versions. Subsequently, a sample of autistic and non-autistic adults (N = 302), matched on age, sex, and general cognitive ability, completed both versions of the new SQ-A-2, as well as the widely-used 10-item Autism-Quotient (AQ-10). Autistic participants also rated their preferences for Original versus Adapted items, and provided qualitative responses for their reasoning.
resultsOverall, the self-report version of the SQ-A-2 demonstrated excellent internal reliability and convergent validity with the AQ-10, and autistic adults scored significantly higher than non-autistic adults. This group difference was greater for the Adapted compared to the Original version of the SQ-A-2, suggesting autistic consultation may facilitate the development of clinically-useful measures. Additionally, autistic participants preferred the wording of the Adapted versus Original items, both quantitatively and qualitatively. LIMITATIONS: Our findings may not generalise to autistic people with intellectual disability. Ethnicity data was not collected.
conclusionsThe adapted version of the SQ-A-2 has the potential to be a valid, clinically useful questionnaire for measuring DSM-5 signs of autism across the lifespan. Our findings also highlight the utility of incorporating autistic input into measure development. Further psychometric testing of the SQ-A-2 in larger, more diverse samples, including the informant-report version, is now required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.